[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Bio-Pharma Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

July 2023 | 121 pages | ID: G0B47121145FEN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Bio-Pharma market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Bio-Pharma market are covered in Chapter 9:

Abbott Laboratories
Pfizer
Bayer AG
Sanofi, Amgen
AbbVie
Biogen Idec
Johnson & Johnson Services
Novartis AG GlaxoSmithKline Plc
Eli Lilly and Company
F. Hoffmann-La Roche AG
Merck & Co., Inc
Bristol-Myers Squibb Company
AstraZeneca PLC

In Chapter 5 and Chapter 7.3, based on types, the Bio-Pharma market from 2017 to 2027 is primarily split into:

Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others


In Chapter 6 and Chapter 7.4, based on applications, the Bio-Pharma market from 2017 to 2027 covers:

Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Bio-Pharma market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Bio-Pharma Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 BIO-PHARMA MARKET OVERVIEW

1.1 Product Overview and Scope of Bio-Pharma Market
1.2 Bio-Pharma Market Segment by Type
  1.2.1 Global Bio-Pharma Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Bio-Pharma Market Segment by Application
  1.3.1 Bio-Pharma Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Bio-Pharma Market, Region Wise (2017-2027)
  1.4.1 Global Bio-Pharma Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Bio-Pharma Market Status and Prospect (2017-2027)
  1.4.3 Europe Bio-Pharma Market Status and Prospect (2017-2027)
  1.4.4 China Bio-Pharma Market Status and Prospect (2017-2027)
  1.4.5 Japan Bio-Pharma Market Status and Prospect (2017-2027)
  1.4.6 India Bio-Pharma Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Bio-Pharma Market Status and Prospect (2017-2027)
  1.4.8 Latin America Bio-Pharma Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Bio-Pharma Market Status and Prospect (2017-2027)
1.5 Global Market Size of Bio-Pharma (2017-2027)
  1.5.1 Global Bio-Pharma Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Bio-Pharma Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Bio-Pharma Market

2 INDUSTRY OUTLOOK

2.1 Bio-Pharma Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Bio-Pharma Market Drivers Analysis
2.4 Bio-Pharma Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Bio-Pharma Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Bio-Pharma Industry Development

3 GLOBAL BIO-PHARMA MARKET LANDSCAPE BY PLAYER

3.1 Global Bio-Pharma Sales Volume and Share by Player (2017-2022)
3.2 Global Bio-Pharma Revenue and Market Share by Player (2017-2022)
3.3 Global Bio-Pharma Average Price by Player (2017-2022)
3.4 Global Bio-Pharma Gross Margin by Player (2017-2022)
3.5 Bio-Pharma Market Competitive Situation and Trends
  3.5.1 Bio-Pharma Market Concentration Rate
  3.5.2 Bio-Pharma Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL BIO-PHARMA SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Bio-Pharma Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Bio-Pharma Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Bio-Pharma Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Bio-Pharma Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Bio-Pharma Market Under COVID-19
4.5 Europe Bio-Pharma Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Bio-Pharma Market Under COVID-19
4.6 China Bio-Pharma Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Bio-Pharma Market Under COVID-19
4.7 Japan Bio-Pharma Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Bio-Pharma Market Under COVID-19
4.8 India Bio-Pharma Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Bio-Pharma Market Under COVID-19
4.9 Southeast Asia Bio-Pharma Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Bio-Pharma Market Under COVID-19
4.10 Latin America Bio-Pharma Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Bio-Pharma Market Under COVID-19
4.11 Middle East and Africa Bio-Pharma Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Bio-Pharma Market Under COVID-19

5 GLOBAL BIO-PHARMA SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Bio-Pharma Sales Volume and Market Share by Type (2017-2022)
5.2 Global Bio-Pharma Revenue and Market Share by Type (2017-2022)
5.3 Global Bio-Pharma Price by Type (2017-2022)
5.4 Global Bio-Pharma Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Bio-Pharma Sales Volume, Revenue and Growth Rate of Monoclonal Antibodies (2017-2022)
  5.4.2 Global Bio-Pharma Sales Volume, Revenue and Growth Rate of Recombinant Proteins (2017-2022)
  5.4.3 Global Bio-Pharma Sales Volume, Revenue and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) (2017-2022)
  5.4.4 Global Bio-Pharma Sales Volume, Revenue and Growth Rate of Interferons (2017-2022)
  5.4.5 Global Bio-Pharma Sales Volume, Revenue and Growth Rate of Recombinant Human Insulin (2017-2022)
  5.4.6 Global Bio-Pharma Sales Volume, Revenue and Growth Rate of Erythropoietin (2017-2022)
  5.4.7 Global Bio-Pharma Sales Volume, Revenue and Growth Rate of Vaccines (2017-2022)
  5.4.8 Global Bio-Pharma Sales Volume, Revenue and Growth Rate of Growth Hormones (2017-2022)
  5.4.9 Global Bio-Pharma Sales Volume, Revenue and Growth Rate of Purified Proteins (2017-2022)
  5.4.10 Global Bio-Pharma Sales Volume, Revenue and Growth Rate of Others (2017-2022)

6 GLOBAL BIO-PHARMA MARKET ANALYSIS BY APPLICATION

6.1 Global Bio-Pharma Consumption and Market Share by Application (2017-2022)
6.2 Global Bio-Pharma Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Bio-Pharma Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Bio-Pharma Consumption and Growth Rate of Metabolic Disorders (2017-2022)
  6.3.2 Global Bio-Pharma Consumption and Growth Rate of Oncology (2017-2022)
  6.3.3 Global Bio-Pharma Consumption and Growth Rate of Neurological Disorders (2017-2022)
  6.3.4 Global Bio-Pharma Consumption and Growth Rate of Cardiovascular Diseases (2017-2022)
  6.3.5 Global Bio-Pharma Consumption and Growth Rate of Inflammatory and Infectious Diseases (2017-2022)
  6.3.6 Global Bio-Pharma Consumption and Growth Rate of Others (2017-2022)

7 GLOBAL BIO-PHARMA MARKET FORECAST (2022-2027)

7.1 Global Bio-Pharma Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Bio-Pharma Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Bio-Pharma Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Bio-Pharma Price and Trend Forecast (2022-2027)
7.2 Global Bio-Pharma Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Bio-Pharma Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Bio-Pharma Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Bio-Pharma Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Bio-Pharma Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Bio-Pharma Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Bio-Pharma Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Bio-Pharma Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Bio-Pharma Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Bio-Pharma Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Bio-Pharma Revenue and Growth Rate of Monoclonal Antibodies (2022-2027)
  7.3.2 Global Bio-Pharma Revenue and Growth Rate of Recombinant Proteins (2022-2027)
  7.3.3 Global Bio-Pharma Revenue and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) (2022-2027)
  7.3.4 Global Bio-Pharma Revenue and Growth Rate of Interferons (2022-2027)
  7.3.5 Global Bio-Pharma Revenue and Growth Rate of Recombinant Human Insulin (2022-2027)
  7.3.6 Global Bio-Pharma Revenue and Growth Rate of Erythropoietin (2022-2027)
  7.3.7 Global Bio-Pharma Revenue and Growth Rate of Vaccines (2022-2027)
  7.3.8 Global Bio-Pharma Revenue and Growth Rate of Growth Hormones (2022-2027)
  7.3.9 Global Bio-Pharma Revenue and Growth Rate of Purified Proteins (2022-2027)
  7.3.10 Global Bio-Pharma Revenue and Growth Rate of Others (2022-2027)
7.4 Global Bio-Pharma Consumption Forecast by Application (2022-2027)
  7.4.1 Global Bio-Pharma Consumption Value and Growth Rate of Metabolic Disorders(2022-2027)
  7.4.2 Global Bio-Pharma Consumption Value and Growth Rate of Oncology(2022-2027)
  7.4.3 Global Bio-Pharma Consumption Value and Growth Rate of Neurological Disorders(2022-2027)
  7.4.4 Global Bio-Pharma Consumption Value and Growth Rate of Cardiovascular Diseases(2022-2027)
  7.4.5 Global Bio-Pharma Consumption Value and Growth Rate of Inflammatory and Infectious Diseases(2022-2027)
  7.4.6 Global Bio-Pharma Consumption Value and Growth Rate of Others(2022-2027)
7.5 Bio-Pharma Market Forecast Under COVID-19

8 BIO-PHARMA MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Bio-Pharma Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Bio-Pharma Analysis
8.6 Major Downstream Buyers of Bio-Pharma Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Bio-Pharma Industry

9 PLAYERS PROFILES

9.1 Abbott Laboratories
  9.1.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Bio-Pharma Product Profiles, Application and Specification
  9.1.3 Abbott Laboratories Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 Pfizer
  9.2.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Bio-Pharma Product Profiles, Application and Specification
  9.2.3 Pfizer Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Bayer AG
  9.3.1 Bayer AG Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Bio-Pharma Product Profiles, Application and Specification
  9.3.3 Bayer AG Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Sanofi, Amgen
  9.4.1 Sanofi, Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Bio-Pharma Product Profiles, Application and Specification
  9.4.3 Sanofi, Amgen Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 AbbVie
  9.5.1 AbbVie Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Bio-Pharma Product Profiles, Application and Specification
  9.5.3 AbbVie Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Biogen Idec
  9.6.1 Biogen Idec Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Bio-Pharma Product Profiles, Application and Specification
  9.6.3 Biogen Idec Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Johnson & Johnson Services
  9.7.1 Johnson & Johnson Services Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Bio-Pharma Product Profiles, Application and Specification
  9.7.3 Johnson & Johnson Services Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Novartis AG GlaxoSmithKline Plc
  9.8.1 Novartis AG GlaxoSmithKline Plc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Bio-Pharma Product Profiles, Application and Specification
  9.8.3 Novartis AG GlaxoSmithKline Plc Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Eli Lilly and Company
  9.9.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Bio-Pharma Product Profiles, Application and Specification
  9.9.3 Eli Lilly and Company Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis
9.10 F. Hoffmann-La Roche AG
  9.10.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
  9.10.2 Bio-Pharma Product Profiles, Application and Specification
  9.10.3 F. Hoffmann-La Roche AG Market Performance (2017-2022)
  9.10.4 Recent Development
  9.10.5 SWOT Analysis
9.11 Merck & Co., Inc
  9.11.1 Merck & Co., Inc Basic Information, Manufacturing Base, Sales Region and Competitors
  9.11.2 Bio-Pharma Product Profiles, Application and Specification
  9.11.3 Merck & Co., Inc Market Performance (2017-2022)
  9.11.4 Recent Development
  9.11.5 SWOT Analysis
9.12 Bristol-Myers Squibb Company
  9.12.1 Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Region and Competitors
  9.12.2 Bio-Pharma Product Profiles, Application and Specification
  9.12.3 Bristol-Myers Squibb Company Market Performance (2017-2022)
  9.12.4 Recent Development
  9.12.5 SWOT Analysis
9.13 AstraZeneca PLC
  9.13.1 AstraZeneca PLC Basic Information, Manufacturing Base, Sales Region and Competitors
  9.13.2 Bio-Pharma Product Profiles, Application and Specification
  9.13.3 AstraZeneca PLC Market Performance (2017-2022)
  9.13.4 Recent Development
  9.13.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES

Figure Bio-Pharma Product Picture
Table Global Bio-Pharma Market Sales Volume and CAGR (%) Comparison by Type
Table Bio-Pharma Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Bio-Pharma Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Bio-Pharma Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Bio-Pharma Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Bio-Pharma Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Bio-Pharma Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Bio-Pharma Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Bio-Pharma Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Bio-Pharma Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Bio-Pharma Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Bio-Pharma Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Bio-Pharma Industry Development
Table Global Bio-Pharma Sales Volume by Player (2017-2022)
Table Global Bio-Pharma Sales Volume Share by Player (2017-2022)
Figure Global Bio-Pharma Sales Volume Share by Player in 2021
Table Bio-Pharma Revenue (Million USD) by Player (2017-2022)
Table Bio-Pharma Revenue Market Share by Player (2017-2022)
Table Bio-Pharma Price by Player (2017-2022)
Table Bio-Pharma Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Bio-Pharma Sales Volume, Region Wise (2017-2022)
Table Global Bio-Pharma Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Bio-Pharma Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Bio-Pharma Sales Volume Market Share, Region Wise in 2021
Table Global Bio-Pharma Revenue (Million USD), Region Wise (2017-2022)
Table Global Bio-Pharma Revenue Market Share, Region Wise (2017-2022)
Figure Global Bio-Pharma Revenue Market Share, Region Wise (2017-2022)
Figure Global Bio-Pharma Revenue Market Share, Region Wise in 2021
Table Global Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Bio-Pharma Sales Volume by Type (2017-2022)
Table Global Bio-Pharma Sales Volume Market Share by Type (2017-2022)
Figure Global Bio-Pharma Sales Volume Market Share by Type in 2021
Table Global Bio-Pharma Revenue (Million USD) by Type (2017-2022)
Table Global Bio-Pharma Revenue Market Share by Type (2017-2022)
Figure Global Bio-Pharma Revenue Market Share by Type in 2021
Table Bio-Pharma Price by Type (2017-2022)
Figure Global Bio-Pharma Sales Volume and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2017-2022)
Figure Global Bio-Pharma Sales Volume and Growth Rate of Recombinant Proteins (2017-2022)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Recombinant Proteins (2017-2022)
Figure Global Bio-Pharma Sales Volume and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) (2017-2022)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) (2017-2022)
Figure Global Bio-Pharma Sales Volume and Growth Rate of Interferons (2017-2022)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Interferons (2017-2022)
Figure Global Bio-Pharma Sales Volume and Growth Rate of Recombinant Human Insulin (2017-2022)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Recombinant Human Insulin (2017-2022)
Figure Global Bio-Pharma Sales Volume and Growth Rate of Erythropoietin (2017-2022)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Erythropoietin (2017-2022)
Figure Global Bio-Pharma Sales Volume and Growth Rate of Vaccines (2017-2022)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Vaccines (2017-2022)
Figure Global Bio-Pharma Sales Volume and Growth Rate of Growth Hormones (2017-2022)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Growth Hormones (2017-2022)
Figure Global Bio-Pharma Sales Volume and Growth Rate of Purified Proteins (2017-2022)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Purified Proteins (2017-2022)
Figure Global Bio-Pharma Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Bio-Pharma Consumption by Application (2017-2022)
Table Global Bio-Pharma Consumption Market Share by Application (2017-2022)
Table Global Bio-Pharma Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Bio-Pharma Consumption Revenue Market Share by Application (2017-2022)
Table Global Bio-Pharma Consumption and Growth Rate of Metabolic Disorders (2017-2022)
Table Global Bio-Pharma Consumption and Growth Rate of Oncology (2017-2022)
Table Global Bio-Pharma Consumption and Growth Rate of Neurological Disorders (2017-2022)
Table Global Bio-Pharma Consumption and Growth Rate of Cardiovascular Diseases (2017-2022)
Table Global Bio-Pharma Consumption and Growth Rate of Inflammatory and Infectious Diseases (2017-2022)
Table Global Bio-Pharma Consumption and Growth Rate of Others (2017-2022)
Figure Global Bio-Pharma Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Bio-Pharma Price and Trend Forecast (2022-2027)
Figure USA Bio-Pharma Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Bio-Pharma Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Bio-Pharma Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Bio-Pharma Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Bio-Pharma Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Bio-Pharma Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Bio-Pharma Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Bio-Pharma Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Bio-Pharma Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Bio-Pharma Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Bio-Pharma Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Bio-Pharma Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Bio-Pharma Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Bio-Pharma Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Bio-Pharma Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Bio-Pharma Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Bio-Pharma Market Sales Volume Forecast, by Type
Table Global Bio-Pharma Sales Volume Market Share Forecast, by Type
Table Global Bio-Pharma Market Revenue (Million USD) Forecast, by Type
Table Global Bio-Pharma Revenue Market Share Forecast, by Type
Table Global Bio-Pharma Price Forecast, by Type
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Monoclonal Antibodies (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Recombinant Proteins (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Recombinant Proteins (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Interferons (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Interferons (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Recombinant Human Insulin (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Recombinant Human Insulin (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Erythropoietin (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Erythropoietin (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Vaccines (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Vaccines (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Growth Hormones (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Growth Hormones (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Purified Proteins (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Purified Proteins (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Bio-Pharma Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Bio-Pharma Market Consumption Forecast, by Application
Table Global Bio-Pharma Consumption Market Share Forecast, by Application
Table Global Bio-Pharma Market Revenue (Million USD) Forecast, by Application
Table Global Bio-Pharma Revenue Market Share Forecast, by Application
Figure Global Bio-Pharma Consumption Value (Million USD) and Growth Rate of Metabolic Disorders (2022-2027)
Figure Global Bio-Pharma Consumption Value (Million USD) and Growth Rate of Oncology (2022-2027)
Figure Global Bio-Pharma Consumption Value (Million USD) and Growth Rate of Neurological Disorders (2022-2027)
Figure Global Bio-Pharma Consumption Value (Million USD) and Growth Rate of Cardiovascular Diseases (2022-2027)
Figure Global Bio-Pharma Consumption Value (Million USD) and Growth Rate of Inflammatory and Infectious Diseases (2022-2027)
Figure Global Bio-Pharma Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Bio-Pharma Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Abbott Laboratories Profile
Table Abbott Laboratories Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Laboratories Bio-Pharma Sales Volume and Growth Rate
Figure Abbott Laboratories Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Bio-Pharma Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Bayer AG Profile
Table Bayer AG Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer AG Bio-Pharma Sales Volume and Growth Rate
Figure Bayer AG Revenue (Million USD) Market Share 2017-2022
Table Sanofi, Amgen Profile
Table Sanofi, Amgen Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi, Amgen Bio-Pharma Sales Volume and Growth Rate
Figure Sanofi, Amgen Revenue (Million USD) Market Share 2017-2022
Table AbbVie Profile
Table AbbVie Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AbbVie Bio-Pharma Sales Volume and Growth Rate
Figure AbbVie Revenue (Million USD) Market Share 2017-2022
Table Biogen Idec Profile
Table Biogen Idec Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biogen Idec Bio-Pharma Sales Volume and Growth Rate
Figure Biogen Idec Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Services Profile
Table Johnson & Johnson Services Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Services Bio-Pharma Sales Volume and Growth Rate
Figure Johnson & Johnson Services Revenue (Million USD) Market Share 2017-2022
Table Novartis AG GlaxoSmithKline Plc Profile
Table Novartis AG GlaxoSmithKline Plc Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis AG GlaxoSmithKline Plc Bio-Pharma Sales Volume and Growth Rate
Figure Novartis AG GlaxoSmithKline Plc Revenue (Million USD) Market Share 2017-2022
Table Eli Lilly and Company Profile
Table Eli Lilly and Company Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly and Company Bio-Pharma Sales Volume and Growth Rate
Figure Eli Lilly and Company Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche AG Bio-Pharma Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche AG Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc Profile
Table Merck & Co., Inc Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc Bio-Pharma Sales Volume and Growth Rate
Figure Merck & Co., Inc Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Company Bio-Pharma Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Company Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca PLC Profile
Table AstraZeneca PLC Bio-Pharma Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca PLC Bio-Pharma Sales Volume and Growth Rate
Figure AstraZeneca PLC Revenue (Million USD) Market Share 2017-2022


More Publications